{
    "Trade/Device Name(s)": [
        "endo.digital Platform",
        "endo.digital Algorithm",
        "endo.digital Bolus Calculator",
        "DreaMed Diary App"
    ],
    "Submitter Information": "DreaMed Diabetes Ltd.",
    "510(k) Number": "K232722",
    "Predicate Device Reference 510(k) Number(s)": [
        "K210561"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "QCC",
        "NDC"
    ],
    "Summary Letter Date": "October 3, 2023",
    "Summary Letter Received Date": "September 5, 2023",
    "Submission Date": "August 29, 2023",
    "Regulation Number(s)": [
        "21 CFR 862.1358",
        "21 CFR 868.1890"
    ],
    "Regulation Name(s)": [
        "Insulin Therapy Adjustment Device",
        "Calculator, Drug Dose"
    ],
    "Analyte Class(es)": [
        "endocrine",
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose",
        "Insulin dosing",
        "Meal data"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "endo.digital Platform (web and mobile applications)",
        "DreaMed Diary App"
    ],
    "Method(s)/Technology(ies)": [
        "Software",
        "Decision-support algorithm"
    ],
    "Methodologies": [
        "Algorithm-based therapy adjustment",
        "Data analysis of CGM and SMBG",
        "Dose calculation"
    ],
    "Submission Type(s)": [
        "Software",
        "Algorithm",
        "Calculator",
        "Platform"
    ],
    "Document Summary": "FDA 510(k) summary for endo.digital Platform software for diabetes management and insulin therapy adjustment recommendations.",
    "Indications for Use Summary": "Intended for the management of diabetes by patients and healthcare providers, including data reporting, monitoring, and generating insulin therapy recommendations using web and mobile applications.",
    "fda_folder": "Clinical Chemistry"
}